MedPath

Therapy of frequent relapsing, steroid-sensitive nephrotic syndrome in childhood: efficacy of mycophenolate mofetil versus cyclosporin A

Completed
Conditions
Idiopathic nephrotic syndrome
Urological and Genital Diseases
Nephrotic syndrome
Registration Number
ISRCTN61976169
Lead Sponsor
Hoffmann-La Roche AG (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
55
Inclusion Criteria

1. Children aged 3 - 17 years
2. Frequent relapses of steroid-sensitive nephrotic syndrome, associated with minimal changes on renal biopsy
3. Glomerular Filtration Rate (GFR) greater than 70 ml/min

Exclusion Criteria

1. Other histological findings on renal biopsy
2. Other severe concomittant diseases
3. Decreased GFR

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath